Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
BlackRock Health Sciences Trust (BME)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/20/2025: BME (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 7.66% | Avg. Invested days 52 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 10/20/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 468.11M USD | Price to earnings Ratio 22.22 | 1Y Target Price - |
Price to earnings Ratio 22.22 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.63 | 52 Weeks Range 33.44 - 39.99 | Updated Date 06/29/2025 |
52 Weeks Range 33.44 - 39.99 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 8.68% | Basic EPS (TTM) 1.63 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 309.96% | Operating Margin (TTM) 1.96% |
Management Effectiveness
Return on Assets (TTM) 0.1% | Return on Equity (TTM) 4.14% |
Valuation
Trailing PE 22.22 | Forward PE - | Enterprise Value 480385856 | Price to Sales(TTM) 61.86 |
Enterprise Value 480385856 | Price to Sales(TTM) 61.86 | ||
Enterprise Value to Revenue 19.45 | Enterprise Value to EBITDA - | Shares Outstanding 12924100 | Shares Floating - |
Shares Outstanding 12924100 | Shares Floating - | ||
Percent Insiders - | Percent Institutions 21.79 |
Upturn AI SWOT
BlackRock Health Sciences Trust
Company Overview
History and Background
BlackRock Health Sciences Trust (BME) is a closed-end fund focused on investing in health sciences companies. Launched to provide investors exposure to the healthcare sector, it leverages BlackRock's expertise in investment management.
Core Business Areas
- Investment Management: Actively manages a portfolio of equity securities in companies operating in the health sciences industry.
Leadership and Structure
The fund is managed by BlackRock Advisors, LLC, a subsidiary of BlackRock, Inc. Leadership comprises portfolio managers with expertise in healthcare investments. The fund operates under a board of directors responsible for oversight.
Top Products and Market Share
Key Offerings
- Investment Fund (BME): BME is a closed-end fund aiming for current income, current gains and long-term capital appreciation by investing primarily in equity securities of companies engaged in the health sciences and related industries. Market share not directly applicable to closed-end funds; competes for investor capital against other investment options. Competitors include Tekla Healthcare Opportunities Fund (THQ) and Columbia Seligman Premium Healthcare Opportunities Fund (CSQ).
Market Dynamics
Industry Overview
The health sciences industry is characterized by innovation, regulation, and demographic trends such as aging populations. It includes pharmaceuticals, biotechnology, medical devices, healthcare services, and related fields.
Positioning
BlackRock Health Sciences Trust is positioned as an investment vehicle offering access to the health sciences sector through actively managed equity investments. Its competitive advantage lies in BlackRock's research capabilities and investment expertise.
Total Addressable Market (TAM)
The TAM for healthcare investments is very large, driven by global healthcare spending, estimated to be in the trillions of dollars annually. BME captures a small portion of this through its focused fund.
Upturn SWOT Analysis
Strengths
- Experienced management team
- Access to BlackRock's research resources
- Diversified portfolio within the health sciences sector
- Focus on income generation
Weaknesses
- High expense ratio compared to passive investments
- Susceptibility to market volatility in the healthcare sector
- Closed-end fund structure can lead to trading at a discount to NAV
Opportunities
- Growing demand for healthcare services due to aging populations
- Technological advancements in healthcare
- Expansion into emerging markets
- Increasing investor interest in ESG (Environmental, Social, and Governance) investing within healthcare
Threats
- Changes in healthcare regulations and policies
- Patent expirations and generic competition
- Economic downturns affecting healthcare spending
- Increased competition from other investment funds
Competitors and Market Share
Key Competitors
- Tekla Healthcare Opportunities Fund (THQ)
- Columbia Seligman Premium Healthcare Opportunities Fund (CSQ)
- Healthcare Services Group (HCSG)
Competitive Landscape
BME benefits from BlackRock's brand and resources but faces competition from other specialized healthcare funds. Performance and expense ratios are key differentiators.
Growth Trajectory and Initiatives
Historical Growth: BME's historical growth is tied to the performance of the health sciences sector and the fund's investment strategy.
Future Projections: Future growth is dependent on factors such as healthcare spending trends, technological innovation, and regulatory developments. Analyst estimates vary based on these factors.
Recent Initiatives: Recent initiatives would involve changes to the fund's investment strategy, portfolio composition, or expense management.
Summary
BlackRock Health Sciences Trust (BME) offers investors exposure to the healthcare sector through an actively managed closed-end fund. The fund benefits from BlackRock's expertise but faces competition and sector-specific risks. Its performance is tied to the health sciences industry, and investors should consider its expense ratio and potential for trading at a discount. Demographics and growing demand will increase opportunities for the company. Regulation is the companies biggest risk.
Peer Comparison
Sources and Disclaimers
Data Sources:
- BlackRock official website
- SEC filings
- Financial data providers (e.g., Bloomberg, Reuters)
- Analyst reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual risk tolerance and due diligence. Market data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About BlackRock Health Sciences Trust
Exchange NYSE | Headquaters New York, NY, United States | ||
IPO Launch date 2005-03-29 | CEO - | ||
Sector Financial Services | Industry Asset Management | Full time employees - | |
Full time employees - | |||
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.